Intrinsic Value of S&P & Nasdaq Contact Us

Evotec SE EVO NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • DE • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+124.4%

Evotec SE (EVO) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 4 recommend buying, 3 recommend holding, and 0 recommend selling.

The analyst consensus price target for EVO is $7.00, representing a +124.4% upside from the current price of $3.12. Price targets range from a low of $7.00 to a high of $7.00.

Analyst Consensus — EVO

Buy
Strong Buy
0
Buy
4
Hold
3
Sell
0
Strong Sell
0
7 analysts
Price Targets
Consensus$7.00
High$7.00
Low$7.00
Median$7.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg$7.00
All-Time Count4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message